2018
DOI: 10.37358/rc.18.9.6540
|View full text |Cite
|
Sign up to set email alerts
|

Mepivacaine Hydrochloride - an Efficient Local Anesthetic Solution for the Electroresection of the Benign and Preneoplastic Lesions of the Cervix and Uterus

Abstract: We are constantly concerned about improving the diagnostic and treatment conditions we offer to our patients, and starting from the observation that the widespread use of Mepivastesin 30 mg / mL(Mepivacaine Hydrochloride) anesthesia in dental and even buccal-facial interventions has a real success and increased safety profile, inspired and encouraged by its use for the local anesthesia during diagnostic hysteroscopy, we started to use this anesthetic substance in gynecology, for the local anesthesia necessary … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
6
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
5

Relationship

4
1

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 2 publications
0
6
0
Order By: Relevance
“…A meta-analysis published in 2008 shows similar results in terms of patient safety (ovarian hyperstimulation syndrome) and clinical outcomes (pregnancy rate) in both ovarian stimulation with hMG and ovarian stimulation with FSHr [28]. Another meta-analysis of seven randomized trials involving 2159 patients showed a 4% higher pregnancy rate in the hMG-stimulated group of patients in the longagonist protocol versus the FSHr-stimulated group of patients in the same type protocol [32]. Another metaanalysis published in 2017, which included 20 prospective studies and 5512 patients showed a significantly higher number of oocytes in the FSHr group than in the hMG group (p <0.001).…”
Section: Resultsmentioning
confidence: 87%
“…A meta-analysis published in 2008 shows similar results in terms of patient safety (ovarian hyperstimulation syndrome) and clinical outcomes (pregnancy rate) in both ovarian stimulation with hMG and ovarian stimulation with FSHr [28]. Another meta-analysis of seven randomized trials involving 2159 patients showed a 4% higher pregnancy rate in the hMG-stimulated group of patients in the longagonist protocol versus the FSHr-stimulated group of patients in the same type protocol [32]. Another metaanalysis published in 2017, which included 20 prospective studies and 5512 patients showed a significantly higher number of oocytes in the FSHr group than in the hMG group (p <0.001).…”
Section: Resultsmentioning
confidence: 87%
“…The improvement of these parameters depends very much on the health policies and the practice of each state [33][34][35][36][37][38][39][40][41].…”
Section: Discussionmentioning
confidence: 99%
“…Revascularization attempts can often be difficult [35]. Here is how the perception of a problem can be changed by the angle of view from which we look [36][37][38][39][40][41][42][43][44]. This study emphasised the connection between them in terms of pathophysiological mechanisms and severity of complications, both having a huge impact as DALYs contributors, shortening life expectancy and dramatically decreasing the quality of life.…”
Section: Discussionmentioning
confidence: 99%